European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“ESMOGynae26: last days to register! Join a global network of experts exploring the latest advances in diagnosis, biology and therapy in gynaecological cancers.
This event will include educational and scientific sessions covering:
- Practice-changing progress in the treatment of patients with gynaecological cancers
- Recent developments in therapies integrating PARP inhibitors, targeted agents and ADCs for managing patients with ovarian cancer
- State-of-the-art in diagnosis and management of cervical and endometrial cancers
- Bench to bedside research perspectives in gynaecological oncology
- Novel therapeutic strategies for rare gynaecological cancers
Comment YES if you are joining us in Copenhagen.”
Other articles from European Society for Medical Oncology.